212 related articles for article (PubMed ID: 15538094)
1. Combination angiotensin receptor blocker/hydrochlorothiazide as initial therapy in the treatment of patients with severe hypertension.
Salerno CM; Demopoulos L; Mukherjee R; Gradman AH
J Clin Hypertens (Greenwich); 2004 Nov; 6(11):614-20. PubMed ID: 15538094
[TBL] [Abstract][Full Text] [Related]
2. Efficacy, tolerability, and quality of life of losartan, alone or with hydrochlorothiazide, versus nifedipine GITS in patients with essential hypertension.
Weir MR; Elkins M; Liss C; Vrecenak AJ; Barr E; Edelman JM
Clin Ther; 1996; 18(3):411-28. PubMed ID: 8829017
[TBL] [Abstract][Full Text] [Related]
3. Effect of combination therapy with the angiotensin receptor blocker losartan plus hydrochlorothiazide on brain perfusion in patients with both hypertension and cerebral hemodynamic impairment due to symptomatic chronic major cerebral artery steno-occlusive disease: a SPECT study.
Saura H; Ogasawara K; Suzuki T; Kuroda H; Yamashita T; Kobayashi M; Terasaki K; Ogawa A
Cerebrovasc Dis; 2012; 33(4):354-61. PubMed ID: 22433127
[TBL] [Abstract][Full Text] [Related]
4. Adding thiazide to a renin-angiotensin blocker improves left ventricular relaxation and improves heart failure in patients with hypertension.
Ito H; Ishii K; Kihara H; Kasayuki N; Nakamura F; Shimada K; Fukuda S; Iwakura K; Yoshikawa J;
Hypertens Res; 2012 Jan; 35(1):93-9. PubMed ID: 22011686
[TBL] [Abstract][Full Text] [Related]
5. Significance of estimated salt excretion as a possible predictor of the efficacy of concomitant angiotensin receptor blocker (ARB) and low-dose thiazide in patients with ARB resistance.
Hasegawa H; Kanozawa K; Asakura J; Takayanagi K; Komuro O; Fukada H; Tokushima H; Kogure H; Matsuzawa M; Mitarai T
Hypertens Res; 2013 Sep; 36(9):776-82. PubMed ID: 23615283
[TBL] [Abstract][Full Text] [Related]
6. Effects of losartan versus hydrochlorothiazide on indices of endothelial damage/dysfunction, angiogenesis and tissue factor in essential hypertension.
Chung NA; Beevers DG; Lip G
Blood Press; 2004; 13(3):183-9. PubMed ID: 15223728
[TBL] [Abstract][Full Text] [Related]
7. Comparison of antihypertensive and metabolic effects of losartan and losartan in combination with hydrochlorothiazide--a randomized controlled trial.
Owens P; Kelly L; Nallen R; Ryan D; Fitzgerald D; O'Brien E
J Hypertens; 2000 Mar; 18(3):339-45. PubMed ID: 10726721
[TBL] [Abstract][Full Text] [Related]
8. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
O'Brien E; Barton J; Nussberger J; Mulcahy D; Jensen C; Dicker P; Stanton A
Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081
[TBL] [Abstract][Full Text] [Related]
9. Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).
Ambrosioni E; Bombelli M; Cerasola G; Cipollone F; Ferri C; Grazioli I; Leprotti C; Mancia G; Melzi G; Mugellini A; Mulè G; Palasciano G; Salvetti A; Trimarco B
Adv Ther; 2010 Jun; 27(6):365-80. PubMed ID: 20556561
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension.
Oparil S; Aurup P; Snavely D; Goldberg A
Am J Cardiol; 2001 Mar; 87(6):721-6. PubMed ID: 11249890
[TBL] [Abstract][Full Text] [Related]
11. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
Lacourcière Y; Neutel JM; Schumacher H
Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
[TBL] [Abstract][Full Text] [Related]
12. Effects of high sodium intake and diuretics on the circadian rhythm of blood pressure in type 2 diabetic patients treated with an angiotensin II receptor blocker.
Uzu T; Sakaguchi M; Yokomaku Y; Kume S; Kanasaki M; Isshiki K; Araki SI; Sugiomoto T; Koya D; Haneda M; Kashiwagi A
Clin Exp Nephrol; 2009 Aug; 13(4):300-306. PubMed ID: 19255824
[TBL] [Abstract][Full Text] [Related]
13. The JNC 7 approach compared to conventional treatment in diabetic patients with hypertension: a double-blind trial of initial monotherapy vs. combination therapy.
Fox JC; Leight K; Sutradhar SC; Demopoulos LA; Gleim GW; Lewin AJ; Bakris GL
J Clin Hypertens (Greenwich); 2004 Aug; 6(8):437-42; quiz 443-4. PubMed ID: 15308882
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension.
Oparil S; Barr E; Elkins M; Liss C; Vrecenak A; Edelman J
Clin Ther; 1996; 18(4):608-25. PubMed ID: 8879890
[TBL] [Abstract][Full Text] [Related]
15. Expedited blood pressure control with initial angiotensin II antagonist/diuretic therapy compared with stepped-care therapy in patients with ambulatory systolic hypertension.
Lacourcière Y; Poirier L; Lefebvre J
Can J Cardiol; 2007 Apr; 23(5):377-82. PubMed ID: 17440643
[TBL] [Abstract][Full Text] [Related]
16. A multicenter, randomized, double-blind, placebo-controlled, 8-week trial of the efficacy and tolerability of once-daily losartan 100 mg/hydrochlorothiazide 25 mg and losartan 50 mg/hydrochlorothiazide 12.5 mg in the treatment of moderate-to-severe essential hypertension.
Gradman AH; Brady WE; Gazdick LP; Lyle P; Zeldin RK
Clin Ther; 2002 Jul; 24(7):1049-61. PubMed ID: 12182251
[TBL] [Abstract][Full Text] [Related]
17. Losartan/hydrochlorothiazide combination therapy surpasses high-dose angiotensin receptor blocker in the reduction of morning home blood pressure in patients with morning hypertension.
Hanayama Y; Uchida HA; Nakamura Y; Makino H
Acta Med Okayama; 2012; 66(6):449-59. PubMed ID: 23254579
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy and safety of combination therapy with losartan and hydrochlorothiazide in elderly hypertension].
Eto K; Tsuchihashi T; Abe I; Iida M
Nihon Ronen Igakkai Zasshi; 2002 Mar; 39(2):181-6. PubMed ID: 11974942
[TBL] [Abstract][Full Text] [Related]
19. Losartan/Hydrochlorothiazide: a review of its use in the treatment of hypertension and for stroke risk reduction in patients with hypertension and left ventricular hypertrophy.
Keating GM
Drugs; 2009 Jun; 69(9):1239-65. PubMed ID: 19537840
[TBL] [Abstract][Full Text] [Related]
20. A study of losartan, alone or with hydrochlorothiazide vs nifedipine GITS in elderly patients with diastolic hypertension.
Conlin PR; Elkins M; Liss C; Vrecenak AJ; Barr E; Edelman JM
J Hum Hypertens; 1998 Oct; 12(10):693-9. PubMed ID: 9819017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
